Showing 8881-8890 of 18116 results for "".
- The Dual Threat: Synergistic Health Impacts of Climate Change and Conflicthttps://reachmd.com/news/the-dual-threat-synergistic-health-impacts-of-climate-change-and-conflict/2484373/A new climate–conflict analysis documents how overlapping environmental shocks and armed instability combine to create compounded threats to health. The report maps linked pathways inclu
- High-Flow Nasal Oxygen: An Effective Alternative in Anesthesia Inductionhttps://reachmd.com/news/high-flow-nasal-oxygen-an-effective-alternative-in-anesthesia-induction/2484380/A randomized non-inferiority trial in adults undergoing frame-based stereoelectroencephalography (SEEG) found that high-flow nasal oxygen (HFNO) provides effective oxygenation during anesthesia induction and offers a practical alternative to facemask ventilation when headframes limi
- Evaluating AI in Suicide Risk Detection: Insights from Touro Universityhttps://reachmd.com/news/evaluating-ai-in-suicide-risk-detection-insights-from-touro-university/2484372/Touro University reports an AI system that analyzed conversational language and identified suicide-risk signals missed by standard screening tools — a finding that coul
- Mapping the Genetic Blueprint of the Corpus Callosum: AI and Imaging Insightshttps://reachmd.com/news/mapping-the-genetic-blueprint-of-the-corpus-callosum-ai-and-imaging-insights/2484344/Researchers at USC’s Mark and Mary Stevens Neuroimaging and Informatics Institute have used AI-driven imaging genetics to map the corpus callosum’s genetic architecture, identifying do
- Evaluation of First-Line Intensification in EGFR-Mutant NSCLChttps://reachmd.com/news/evaluation-of-first-line-intensification-in-egfr-mutant-nsclc/2484335/FLAURA2 and MARIPOSA demonstrate that first-line intensification with osimertinib-based combinations significantly prolongs overall survival in NSCLC
- Understanding Growth Impairment in Pediatric Sickle Cell Disease and the Importance of Hydroxyurea Adherencehttps://reachmd.com/news/understanding-growth-impairment-in-pediatric-sickle-cell-disease-and-the-importance-of-hydroxyurea-adherence/2484336/Hydroxyurea adherence strongly influences growth trajectories in children with sickle cell disease, materially changing short‑stature risk and warranting prioritized pediatric follow‑up. Growth impairment is common in pediatric sickle cell cohorts; risk concentrates
- Unpacking Glycan Roles in Psoriasis: Emerging Insights into Immune Traffickinghttps://reachmd.com/news/unpacking-glycan-roles-in-psoriasis-emerging-insights-into-immune-trafficking/2484338/A recent translational study shows that leukocyte surface glycans actively regulate immune-cell entry into psoriatic skin by regulating immune cell movement. The findings demonstrat
- NICE Recommends First Topical JAK Inhibitor for CHE in England and Waleshttps://reachmd.com/news/nice-recommends-first-topical-jak-inhibitor-for-che-in-england-and-wales/2484333/The National Institute for Health and Care Excellence (NICE) has recommended the reimbursement of Anzupgo® (delgocitinib) cream for adult patients with moderate to severe chronic hand eczema (CHE) who have not responded to,
- Cardiovascular Protection Beyond Weight Loss: Insights from the SELECT Trial on Semaglutidehttps://reachmd.com/news/cardiovascular-protection-beyond-weight-loss-insights-from-the-select-trial-on-semaglutide/2484313/The SELECT trial found that semaglutide reduced major adverse cardiovascular events (MACE) independent of weight loss, suggesting a cardioprotective ef
- Enhanced Glycemic Management in Pregnancy: The Role of Closed-Loop Insulin Systemshttps://reachmd.com/news/enhanced-glycemic-management-in-pregnancy-the-role-of-closed-loop-insulin-systems/2484320/A multicenter trial demonstrated that automated closed-loop insulin therapy substantially increased the percentage of time pre